Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tieghemella heckelii aqueous leaf extract is a botanical preparation derived from the leaves of the Tieghemella heckelii tree, a species native to West and Central Africa often referred to as Baku or Cherry Mahogany. While the stem bark of this plant has a history of use in traditional medicine, recent scientific research has explored the anticancer potential of its leaves. In vitro studies have demonstrated that the aqueous extract exhibits significant cytotoxic activity against several human cancer cell lines, including breast (MDA-MB-468), liver (HepG2), and prostate (PC3) cancer. The extract is believed to contain bioactive phytochemicals that induce cell death or inhibit proliferation, though the specific active compounds and their precise molecular mechanisms of action are still being investigated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tieghemella heckelii aqueous leaf extract.